Ventracor (ASX:VCR) is an international medical technology company that has developed a life-saving
heart pump, the VentrAssist™ left ventricular assist system (LVAS) for patients in cardiac failure. The
company is expects to bring the VentrAssist™ to global markets in record time, and obtaining a
significant share of the potential LVAS market, which independent analysts expect to be valued at over
$US5 billion per year.
Read latest news ann !!!!
